Hofseth Biocare ASA (HBC.OL)

Oslo Børs · Financial statements, TTM figures and earnings dates

In fiscal year 2024 (ended December 31, 2024), Hofseth Biocare ASA reported revenue of NOK 256.8M and net income of −NOK 125.3M. Annual financial statements are available for fiscal years 2020 to 2024, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

NOK	FY2024 2024-12-31	FY2023 2023-12-31	FY2022 2022-12-31	FY2021 2021-12-31	FY2020 2020-12-31
Income statement
Revenue	NOK 256.8M	NOK 190.8M	NOK 119.1M	NOK 76.9M	NOK 52.5M
Gross profit	NOK 87.3M	NOK 40.1M	NOK 27.2M	–	–
Operating income	−NOK 105.1M	−NOK 102.5M	−NOK 128.6M	−NOK 118.6M	−NOK 92.0M
Net income	−NOK 125.3M	−NOK 106.7M	−NOK 137.4M	−NOK 126.5M	−NOK 102.1M
Diluted EPS	−NOK 0.30	−NOK 0.27	−NOK 0.37	−NOK 0.35	−NOK 0.31
Cash flow
Operating cash flow	−NOK 9.8M	NOK 2.8M	−NOK 45.2M	−NOK 61.8M	−NOK 61.6M
Capital expenditure	NOK 2.4M	NOK 8.2M	NOK 4.0M	NOK 22.9M	NOK 32.6M
Free cash flow	−NOK 12.2M	−NOK 5.4M	−NOK 49.2M	−NOK 84.7M	−NOK 94.2M
Balance sheet
Cash and equivalents	NOK 25.6M	NOK 23.9M	NOK 32.4M	NOK 49.9M	NOK 172.8M
Total assets	NOK 339.4M	NOK 390.1M	NOK 411.0M	NOK 416.0M	NOK 459.1M
Total liabilities	NOK 280.1M	NOK 349.0M	NOK 263.0M	NOK 275.6M	NOK 195.4M
Total debt	NOK 73.1M	NOK 29.2M	NOK 1.4M	NOK 3.8M	NOK 7.2M
Shareholders' equity	NOK 59.4M	NOK 41.1M	NOK 148.0M	NOK 140.4M	NOK 263.8M

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in NOK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full HBC.OL page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open HBC.OL financials →